The government had notified DPCO, 2013, which covers 680 formulations, with effect from May 15, 2014, replacing the 1995 order that regulated prices of only 74 bulk drugs. (PTI) Centre has allowed pharmaceutical companies to hike rates of 509 ... Financial Express, 2 weeks ago
Your Monthly Medicine Bill Just Got Pricey - New Indian Express, 2 weeks ago
Centre allows pharmas to raise price of 509 drugs; cancer medicines, condoms to cost more - Firstpost.com, 2 weeks ago
2 images for "dpco"
To address the shortage of human albumin in the country on a priority basis, National Pharmaceutical Pricing Authority (NPPA) is contemplating to invoke paragraph 3 of DPCO (Drug Price Control Order) -2013 which empowers it to issue directions to ...PharmaBiz, 1 month ago Gujarat FDCA alerts NPPA on shortage of human albumin seeking immediate intervention PharmaBiz, 1 month ago Only 45 blood banks provide plasma to produce human albumin in state PharmaBiz, 1 month ago NPPA to meet NACO on supply gap problem to address shortage of human plasma PharmaBiz, 2 months ago
NPPA moots to replicate Gujarat FDCA model of efficient reporting of DPCO violation cases across India
Top officials from the National Pharmaceutical Pricing Authority (NPPA) recently visited the Gujarat Food and Drug Control Authority (FDCA) to understand the techniques adopted by the state drug regulatory body in efficiently detecting the cases of ...PharmaBiz, 1 month ago Pharma pricing body chief shunted in less than a year Times of India, 2 weeks ago NPPA Yet to Recover Rs 3680 cr for Drug Price Overcharging New Indian Express, 1 month ago NPPA yet to recover Rs 3,680 cr for drug price overcharging Business Standard India, 1 month ago
Pharma Jan Samadhan, an on-line system launched to take action related to non-availability and overcharging of medicines
All essential medicines specified in the National List of Essential Medicines, 2011 (NLEM) are included in the First Schedule of DPCO, 2013 and are under price control. However, Life saving drugs are not defined in the Drugs (Price Control) Order, 2013.PIB, 4 days ago
Mumbai: The pharmaceutical sector is likely to report moderate growth in the fourth-quarter earnings on fewer abbreviated new drug application (ANDA) approvals in the US and emerging market (EM) currency headwinds. In a report on the pharma ...Pharmacy Choice, 1 week ago Pharmaceutical sector likely to report moderate growth in Q4 earnings DNA India, 1 week ago
As a part of its drive to ensure compliance to the conditions of licence as stipulated under Rule 65 of the Drugs and Cosmetics Rules, 1945, the Maharashtra Food and Drug Administration (FDA) has taken action against a number of wholesalers in ...PharmaBiz, 1 week ago
The Indian pharmaceutical market (IPM) has grown 20.9% for the month of March, clocking a revenue of Rs 7,389 crore. The Indian pharmaceutical market (IPM) has grown 20.9% for the month of March, clocking a revenue of Rs 7,389 crore. ...DNA India, 1 week ago IPM registers Rs 7194 crores in February 2015 Financial Express, 2 weeks ago IPM clocks Rs 7294 crores revenue in January 2015 Financial Express, 1 month ago
In a chat with ET Now, Ajay Srivastava, CEO, Dimensions Consulting Pvt Ltd, talks about the markets and some sectors and stocks. Excerpts: ET Now: Would people take leap of faith in businesses even if the PE multiples are just way too high? Ajay ...Economic Times, 1 week ago
New Delhi, April 8: Essen-tial medicines, including painkillers, anti-anxiety pills, antibiotics, insulin, anti-diabetes drugs and some cancer treatment drugs, have become costlier by 3.8 per cent from April. The government has allowed ...Calcutta Telegraph, 2 weeks ago
The Department of Pharmaceuticals (DoP) has rejected the review application filed by Biological E. Ltd against the fixation/revision of retail prices of Tetanus Toxoid Vaccine by the national drug regulator National Pharmaceutical Pricing Authority ...PharmaBiz, 1 month ago DoP rejects Inventia Healthcare's review application on metformin HCl, gliclazide and pioglitazone tablets PharmaBiz, 1 month ago DoP turns down Ranbaxy's review application on gentamicin, renitidine and dexamethasone injections PharmaBiz, 1 month ago
on your WebpageAdd Widget >Get your members hooked!